SIGN IN SUBSCRIBE

News Update

Cus - Petitioner is only an intermediary for procuring containers and giving the same on lease to the consignees - Directions cannot be issued, while exercising extraordinary jurisdiction, to authorities to release the containers by destuffing the goods: HCGST - Petitioner asserts that he was unaware of the proceedings - Since the tax dues appear to have been recovered, revenue interest has been secured - Matter remanded: HCGST - No opportunity of hearing is granted to the petitioner by the respondent authority while taking adverse view - Only recourse is to remand the matter for passing fresh order in accordance with law: HCGST - Tax demand and penalty were confirmed entirely on the basis of the statement recorded on 26.09.2022 and by disregarding the reply filed and documents annexed thereto - Orders unsustainable, matter remanded: HCGST - Refund - Proper officers have to comply with the provisions of s.54(7) - Claim to be processed within two weeks: HCGST - Since the only reason for passing impugned order is that petitioner had not filed any reply, one opportunity needs to be granted - Matter remitted: HCChina faces acute revenue crunch! Will it reform clunky fiscal system?Arunachal cops bust sex racket; 21 including govt employees arrestedI-T- Not providing cross-examination of maker of the statement on which AO relies upon to take adverse view against an assessee is a serious flaw which render the action of AO a nullity : ITATMajor road accidents: 8 killed in MP & 6 in OdishaI-T- 84-day delay in filing appeal before CIT(A) is condonable, where caused due to assessee's ill health; matter remanded for reconsideration: ITATNSSO reveals joblessness on decline in urban IndiaBharat Pavilion at Cannes Film Festival inauguratedAs protests turn violent, France declares state of emergency in CaledoniaI-T- Amount of enhancement is deemed to be income of previous year in which it is received for purposes of 'enhanced compensation' taxable as capital gain: ITATLawrence Wong assumes office as Singapore’s new PMDoT receives overwhelming response to its Sangam Initiative: 144 participants selectedPutin seeks greater support for war efforts in BeijingI-T- DDT liability is distinct and separate from the liability to pay income-tax on the total income of an assessee : ITATGST - SC tells UoI - Not necessary to make arrest in every caseFirst set of citizenship certificates after notification of CAA Rules, 2024 issuedAssassination attempt at Slovakia PM Fico; Serious injuries reportedCus - Without checking authenticity of certificate of origins, the same cannot be discarded & based on the same, benefit of exemption cannot be denied: CESTATFM says PM’s active monitoring behind infra sector turnaroundCBIC revises tariff value of edible oils, gold and silver6 burnt to death as bus catches fire after ramming into lorry in APCX - Since the appellant has fulfilled procedural requirement as mentioned in Clause 2(a) of Notfn 33/99-CE , refund applications filed by appellant cannot be rejected: CESTAT
 
CSIR-NAL jointly develops Ventilator in record 36 days

 

By TIOL News Service

NEW DELHI, MAY 12, CSIR - National Aerospace Laboratories (NAL) Bangalore, a constituent of lab of CSIR has developed a Non Invasive BiPAP Ventilator in a record time of 36 days to treat COVID-19 patients. BiPAP Non-Invasive ventilator is a microcontroller-based precise closed-loop adaptive control system with a built-in biocompatible "3D printed manifold & coupler" with HEPA filter (Highly Efficient Particulate Air Filter). These unique features help to alleviate the fear of the virus spread. It has features like Spontaneous, CPAP, Timed, AUTO BIPAP modes with provision to connect Oxygen concentrator or Enrichment unit externally.  The system has been certified for safety and performance by NABL accredited agencies. The system has undergone stringent biomedical tests and beta clinical trials at NAL Health Centre.

The major advantage of this machine is that it is simple to use without any specialized nursing, cost effective, compact and configured with majority of indigenous components. This is ideal for treating COVID -19 patients in Wards, Make shift Hospitals, dispensaries and home in current Indian COVID 19 scenario. CSIR-NAL is in process of taking it forward with the regulatory authorities for the approval and expected to get shortly. CSIR-NAL has already initiated dialogue with major public/private industries as a partner for mass production.

DG CSIR, Dr Shekhar C Mande, complemented CSIR NAL team which has enabled a spin-off technology based on its expertise in the aerospace design domain. He also recalled the contribution of CSIR-NAL in the flight of indigenously developed Hansa-3, on May 11 th in 1998, which is one of the achievements that is also celebrated on National Technology Day.

Director CSIR-NAL, Shri Jitendra J. Jadhav stated that based on global experience and specific inputs from pulmonologists in India and abroad, CSIR-NAL developed BIPAP Non Invasive Ventilator with externally connected Oxygen concentrator which will be ideal to treat moderate or mid-stage severe COVID-19 patients who do not require intubation and invasive ventilation .

The success is the culmination of efforts of team of technocrats and medical practitioners under the leadership of Dr. CM Ananda, Head Electronics Dept., Dr.Amarnarayan D, Chief Medical Officer- NAL, Dr. Viren Sardana – Respiratory Physiologist CSIR-IGIB and team of scientists at NAL who have worked relentlessly during Covid-19 restrictions.


 


POST YOUR COMMENTS
   

TIOL Tube Latest

TIOL Tube
Shri N K Singh, recipient of TIOL FISCAL HERITAGE AWARD 2023, delivering his acceptance speech at Fiscal Awards event held on April 6, 2024 at Taj Mahal Hotel, New Delhi.

TOP NEWS

AR not Afar by SK Rahman

VISION 360



Shri Ram Nath Kovind, Hon'ble 14th President of India, addressing the gathering at TIOL Special Awards event.

TII LATEST

TIOLCORPLAWS LATEST